Advertisement

American Association of Hip and Knee Surgeons

Advocacy, Education, Research

‘Advocacy’

Make Our Voice Heard in the AMA

Hip and knee surgery is a small subspecialty, but the AMA is the country’s largest and most visible physician society. Because we help guide the AMA’s direction through a seat in the AMA HOD, the CPT and RUC, the AMA amplifies our voice at both federal and state levels. Hip and knee surgeons cannot afford to be sidelined… Read More

Tom Price Meets with AAHKS in DC

A leadership delegation from AAHKS met with Health and Human Services (HHS) Secretary Tom Price, MD and his health policy counselor in Washington, DC this week to discuss pertinent health care topics. AAHKS President Mark I. Froimson, MD, MBA, Immediate Past President William A. Jiranek, MD, FACS, AAHKS First Vice President Craig J. Della Valle, MD, Advocacy Council… Read More

More Capitol Hill Visits During NOLC

AAHKS at NOLC

Concluding a busy week in Washington, AAHKS President Mark I. Froimson, MD, MBA, Past President William A. Jiranek, MD, FACS, AAHKS First Vice President Craig J. Della Valle, MD, Advocacy Council Chair Richard Iorio, MD and Evidence Based Medicine Committee Chair Adolph J. Yates, MD were joined by 2016-2017 Health Policy Fellow Chancellor F. Gray, MD to advocate… Read More

AAHKS Signs Letter Urging Reduction in Regulatory Burdens

In a letter to CMS Administrator, Seema Verma, AAHKS joined numerous medical societies and subspecialty organizations urging the CMS to ease regulatory burdens. “We urge the Administration to take a series of steps to address these same challenges in MU, PQRS, and VM prior to their replacement by MACRA and minimize the penalties assessed for physicians who tried… Read More

AAHKS Signs on to CEHRT Delay

In a letter to CMS this week, AAHKS signed on with the AMA and other medical societies to request the CMS and ONC delay implementation of the 2015 Edition of certified electronic health record technology (CEHRT) until it’s more widely available on the market. The letter details four reasons for the request to delay. Read the letter.

Tom Price Confirmed to Lead HHS

Sen Barrasso, Dr Santore and Dr Price in 2010

Congressman, Tom Price, MD, was confirmed as the new Secretary of the U.S. Department of Health and Human Services (HHS) early Friday. Dr. Price’s experience as an orthopaedic surgeon gives him a critically important perspective on the real-world impact of health policy including the importance of access, coverage, the doctor-patient relationship, clinical decision making and challenges of navigating… Read More

AAHKS Leaders Meet with Congress

capitol hill

More than 40 Members of the AAHKS Board of Directors, Committee Chairs and staff are in Washington, D. C. to communicate AAHKS’ advocacy agenda to Congress. After hearing from Danielle Steele, Health Policy Counsel to the Energy & Commerce Subcommittee Chairman Michael Burgress (R-TX) and Philo Hall of Epstein Becker & Green about CMMI, they headed to Capitol Hill.… Read More

AAHKS Comments on CMS Patient Relationship Codes

As part of their Medicare Quality Payment Program (QPP), CMS is developing categories of patient relationship codes for use in episodes of care. While AAHKS believes that these codes can ultimately be useful for patient care, some changes do need to be made before utilization. This will be an evolving process but initial comments can be found in… Read More

AAHKS Calls for Repeal of IPAB

AAHKS joined medical specialty societies in a letter to the U.S. Congress asking to repeal the Medicare Independent Payment Advisory Board (IPAB). “The Independent Payment Advisory Board (IPAB), a provision of the Patient Protection and Affordable Care Act (PPACA), not only poses a threat to that access but also, once activated, will shift healthcare costs to consumers in… Read More

Cures Act Approved by House Committee

Following breakthroughs in bipartisan negotiations after the election, the 21st Century Cures Act is on a path toward passage. This long discussed legislation would inject billions in new funding for the National Institutes of Health (NIH) and reform the drug and device review process at the Food and Drug Administration (FDA). AAHKS supported the bill in a joint letter… Read More